Purpose: The identification of a brain tumor imaged with PET or SPECT is usually performed with visual inspection of an expert medical clinician. However an automated diagnostic of such images hasn't been established or applied. In this study, we explored the possibility of establishing an automated statistical analysis for the diagnosis of glioma by means of IPA-SPECT data. Methods: On the basis of a dataset of 100 patients that have undergone MRI and IPA-SPECT acquisition, in this work, we identify an automated workflow. Three different approaches were explored: I. statistical non-parametric mapping analysis (SnPM), II. statistical non-parametric analysis with an increased number of permutations due to sign-flipping function (PALM) and III. statistical parametric analysis (SPM). The automated methods were compared with the visual inspection. Results: The study proved PALM and SPM approaches to have a high diagnostic power. Compared to the parametric methods, the non-parametric method is the mathematically correct approach for the problem in question. If we take the high resolution structural MRI information into account, the diagnostic power of PALM was not significantly inferior to the visual inspection (P = 0.5150), showing an area under the ROC curve (AUC) smaller only by less than 3%. Conclusions: The automated diagnostic method based on statistical inference, here applied to diagnose glioma tumors in IPA-SPECT data, seems to be a promising tool that can support the visual investigation in nuclear medicine. Moreover in the foreseeable future, the presented methodology has a big potential in various application like localization of active tumor tissues in surgical resection or stereotactic radiosurgery.
INTRODUCTION
The gold standard for the diagnosis of brain tumors is magnetic resonance imaging (MRI) and computed tomography (CT) 1 showing with high spatial resolution the distortion of the tissues on the structural image. These techniques are often combined with other imaging modalities, e.g., PET or SPECT 2 based on molecular radiotracers, that provide additional metabolic information about the lesion and the extent of the active neoplastic tissue. The common radiopharmaceutical used in this setting is the L-3[123I]-iodo-a-methyl-tyrosin (IMT) introduced in 1989. 3, 4 The application of IMT is well established in the localization of the tumor and its infiltration into adjacent brain structures. 5, 6 Moreover, in brain tumor tissues, it is rapidly absorbed with an uptake peak at 10-15 min after injection and an early wash-out. This reduces the time of tumor visualization by IMT-SPECT to only within 45 min after injection.
Recently, Hellwig et al. showed a significant increase in uptake of p-[(123)I]iodo-L-phenylalanine (IPA) in tumor tissue compared to normal brain tissue and to non-glioma lesions and a more persistent retention in glioma cells, representing a major advantage in comparison with the afore-mentioned radiotracers commonly used in SPECT tumor imaging. 7 This applies to low -as well as to high -grade gliomas and shows a high specificity for the glioma tumor. 8 The clinical examination of such images is performed with visual inspection by clinical specialists, in nuclear medicine departments, who are required to decide about the malignancy of the lesion according to the criteria for malignant uptake in brain tumors. 9, 10 This process is quite subjective, based on the experience of clinicians, and introduces inter-observer and intra-observer variability. 11 Up until now, automated evaluation for clinical purpose has only been scarcely explored. However, it is largely available and applied in basic research, for example, in the investigation of betweengroup regional cerebral blood flow (rCBF) differences 11 or in the detection of regional cerebral metabolic abnormalities 12 or in the clinical application of nuclear cardiology for myocardial perfusion examination. 13 In this study, we aim to evaluate the feasibility of glioma diagnosis with IPA -SPECT by means of a robust image statistics-tool using two different statistical approaches: (a) parametric statistic and (b) permutation/randomization tests based on non-parametric statistics. Parametric tests require a normally distributed population, with homogeneous variance and independent samples.
14 Non parametric tests, on the contrary, need only the assumption of independent samples. 15 Our hypothesis was that the automatic procedure, based on statistical inference, could facilitate the diagnosis of glioma tumors, assisting the classical visual inspection.
MATERIAL AND METHODS

2.A. Data set
The database included 100 anonymized patients containing for each patient the brain volume IPA-SPECT image, a T1 MRI structural image and a histology report (Table I) .
The SPECT images were collected with a triple -Head gamma camera (MultiSPECT 3, Siemens, Erlangen, Germany). The brain distribution of the tracer was collected in two consecutive times: (a) 30 min and (b) 3 h after the injection of p-[(123)I]-iodo-L-phenylalanine (IPA). The final volume resolution was of 1.78 9 1.78 9 3.56 mm 3 , with a reconstructed image in -plane resolution of 10 mm FWHM. The MRI images were acquired with either a 1.5-Tesla scanner (Sonata, Siemens, Erlangen, Germany) or a 1.0-Tesla scanner (Expert, Siemens, Erlangen, Germany).
The detailed protocol for the data acquisition with the SPECT and the MRI is described in. 7, 8 The research has been carried out in accordance with the Declaration of Helsinki of the World Medical Association and it was approved by the local institutional committee. Informed consent was obtained from all individual participants included in the study.
2.B. Work flow of data analysis
A schematic description of the data analysis workflow is outlined in Fig. 1 .
In order to compare the brain images with a voxel-based analysis technique and produce statistical inference, the following steps were carried out:
• Spatially pre-processing of the IPA-SPECT data positive to the glioma tumor and the MRI images
• Statistical map inference implementation and computing
The spatial pre-processing projects the brain volume in a stereotactic space; this can be done by minimizing the difference between an image and a stereotactic template(s) in the same imaging modality with anatomical coordinates standardized to a common referred space. 16 In functional neuroimaging the Montreal Neurological Institute (MNI) -coordinates 17 are generally used as reference space. To this purpose, the SPM toolbox provides for the structural MRI data a stereotactic T1-template in MNI coordinates.
However, since this is the first work considering applying a voxel-based statistical analysis on IPA-SPECT data, the MNI-template for the specific imaging modality was not available. Then, to proceed with the spatial normalization of the SPECT data, we first had to create the relative stereotactic template in the standard MNI-space. To this end, we used the following steps:
• Generation of a synthetic data (phantom), with similar physical characteristic to the IPA-SPECT image and with standard MNI coordinate
• Spatially normalization of the IPA-SPECT data negative for glioma tumors to the synthetic phantom.
• Building of the IPA-SPECT template, using the normalized volumes from point 2, to be used along the spatial pre-processing for all the IPA-SPECT data.
The realization of the phantom and the final template is detailed in the following paragraph.
2.B.1. Realization of a IPA-SPECT template in MNI -coordinates
A stereotactic phantom-image is a synthetic image with physical characteristics similar to the real data with coordinates systems normalized to the standard MNI system. An empirical observation of the 18 IPA-SPEFCT volumes negative for glioma led us to gather three features common to the images: 1. the uptake of the nuclear tracer in the brain tissues was randomly distributed; all the subjects exhibited 2. a minimum of IPA uptake in the eyes area, and 3. a remarkably higher uptake of IPA in the nose area (Fig. 2) . On the basis of these observations, we generated three synthetic volumes, a, b and c using as starting point the MNI-template head available in SPM-software (Wellcome Department of Cognitive Neurology, London, UK). 18, 19 Finally the image phantom was created by adding the three volumes and taking into account a multiplication factor (ɣ) for the normalization of the intensity distribution (Fig. 3) .
Finally, the synthetic volume was smoothed by a 3D gaussian isotropic filter (10 mm 3 FWHM) to mimic the low-resolution SPECT data. The final phantom volume had 91 9 109 9 91 voxels and voxel size of 2 9 2 9 2 mm 3 ( Fig. 3 ). The synthetic phantom was then used as reference image for the spatial normalization of the 18 IPA-SPECT patients negative to glioma tumor.
The spatial normalization is based on algorithms that minimize the sum of squares difference between the image required to be normalized and a reference image. Simultaneously the deviation of the transformation from its expected value is minimized. Initially a 12 -Parameter affine transformation is computed then the registration is performed by matching the head and scalp of the subject images to the reference image file. 16 Subsequently, the registration matches the brains volumes together by appropriate weighting of the reference image file. Because the images can differ significantly in the scaling, an additional intensity scaling parameter is included in the registration process.
A Bayesian framework is used for the registration providing the maximum posterior probability. The registration is updated iteratively using a Gauss -Newton scheme to maximize the maximum a posteriori (MAP). 20 Moreover the possible variability in head sizes is accounted and implemented into the Bayesian framework to make it more robust and efficient. 20 The MNI-normalized SPECT brains where then averaged together to build the real-data template. Six of the 18 subjects were excluded because of movement artefacts and low image resolution. As final result we obtained an IPA-SPECT template, from 12 real SPECT data, in MNI stereotactic space. The template does not have to be re-created each time during the analysis but it is freely available to be downloaded from the official SPM-software web site URL: http://www.fil.ion. ucl.ac.uk/spm/ext/#IPA_SPECT under the section Templates.
2.B.2. Spatial pre-processing of IPA-SPECT data positive to glioma tumor
Once the IPA-SPECT template was available we could proceed with the spatial pre-processing of the positive tumor data. For this, we used the pre-processing toolbox available in SPM8 (Wellcome Department of Cognitive Neurology, London, UK) and implemented in Matlab FIG. 1. Schematic workflow of the data analysis. The spatial pre-process includes all the transformation on the voxels of the volumes. For the TI-MRI structural we applied normalization onto a stereotactic brain defined by the Montreal Neurological Institute (MNI) by means of T1-template available inside the SPM toolbox. The IPA-SPECT images were first realigned, in order to correct effects associated to the head relocation inside the scanner, and then also normalized onto the NMI stereotactic brain by means of IPA-SPECT template. The template was built for the purpose, using the negative glia-tumor in our data. Finally, the two imaging modalities could be fused in the same coordinate system. For the statistical inference we applied both parametric and non-parametric statistics to infer in the final answer of the analysis: yes (y) or no(n) glia tumor. [Color figure can be viewed at wileyonlinelibrary.com]
Medical Physics, 45 (3), March 2018 7.5-R2009b (Math Works Inc., MA, USA). The scripts are listed in the Appendix A and available as supplemental material. Eventually, MR images and SPECT images, using the affine and non-linear spatial transformations above mentioned, 16 were brought into the same stereotactic standard space allowing the spatial fusion of the two modalities ( Fig. 1) .
Since the intensities in SPECT data are arbitrarily distributed and can, in great extent, differ from patient to patient as well as from acquisition to acquisition, an extra normalization of the intensity distribution of the volume was necessary before the spatial normalization process.
Maxima and minima values compiled from the 30 min and the 3 h IPA -SPECT templates were used in accord with the following formula:
where I subject(normalized) = final normalized intensity value, I subject = intensity of the original image, I subjectmax = maximum intensity value of the original image, I subjectmin = minimum intensity value of the original image, I standardmax = maximum intensity value of the template, I standardmin = minimum intensity value of the template.
2.B.3. Statistics map inference
The statistical analysis was carried out using three different approaches: (a) parametric statistics functions available in SPM8 (Wellcome Trust Centre for Neuroimaging -London) implemented in Matlab (The MathWorks, Inc., Natick, Massachusetts, United States), and using 2 different non-parametric statistics implemented respectively in (b) SnPM13 software (statistical non parametric mapping) -toolbox (URL: http://warwick.ac.uk/snpm) and in (c) Permutation Analysis of Linear Models (PALM) v13-Toolbox 21 also developed in Matlab. The scripts are listed in the Appendix A and available as supplementary material.
For each patient and each time of acquisition, we generated one statistical parametrical map and two statistical nonparametrical maps based respectively on SnPM and PALM.
Generation of individualized statistical parametric maps (SPM):
The parametric approach embodied in Statistical Parametric Mapping is based on the assumption that the data is normally distributed with parameters, like the mean, evaluated in a General Linear Model. Then, the estimated parameters at each voxel are tested under the null hypothesis to infer the significant voxels that survive the statistical threshold (univariate analysis) and finally generate the resulting statistic parametric map (SPM) by means of a Random Field theory. 15, 22 Data with a low degree of freedom, for instance singlesubject studies, which is the case of our SPECT study, will give very imprecise and noisy results when examined with parametric statistics, since the voxel variances estimated from low number of observations are unreliable. Aware of this non-rigorous approach, we used this method as first attempt to investigate the scene of a sensitive statistical method able to detect a positive response in glioma brain tumors with IPA-SPECT with the intention to further verify it with an appropriate statistic, similar to what has been already done by Signorini and colleagues. 12 In this prospective we applied the classical steps to generate the individual sp-maps: the pre-processed data were inserted in a general linear model (GLM) using a two sample t-test, comparing the positive glioma IPA-SPECT data of each patient with the 12 IPA-SPECT negative of certified non-glioma tumor. The relative spm showed the supra-threshold voxels survived at a statistical p value corrected for multiple-comparison (pFWEcorr) < 0.05. The scripts are listed in the Appendix A and available as supplemental material.
Generation of individualized statistical non -parametric maps (SnPM): Non parametric statistics need simpler assumptions than the parametric methods. They are based on permutation test theory, with the only constraint of exchangeability on the observation to satisfy the null hypothesis, 15 meaning that if there is no effect in the study, the experimental conditions are arbitrary, so any readjustment of the labels to the scans would lead to the same statistic image. For small size of samples (n < = 6), a non-parametric test is the only mathematically valid method. 23 In our dataset, the conditions associated with the patients positive to the glioma tumor, called positive con-
from the pool of patients negative to glioma and we pseudo-randomized them into three different groups. Table II shows the seven patients' data that were used to produce a new set of volumes that we applied in the statistical analysis. The final volume recombination was then created by averaging them together with a final output of six normalized volumes called B #1/2/3 and b #1/2/3.
Then, each IPA-positive volume (A/a) was statistically compared to three different B(b) volumes in the respectively time of acquisition, AvsB and avsb.
The statistical design used a condition index of AB#1A-B#2AB#3ab#1ab#2ab#3, 2 blocks (2 repetitions, one after 30 m, and after 3 h) and three elements (exchangeability) per bock (EB) which lead us to a total number of permutations (P) of:
In this case, the statistics were computed for all the possible permutations, creating a permutation distribution. The statistical maps were created with regard to positive changes from the baseline to activation images. After the estimation, the non-parametric statistical maps could be evaluated. The scripts are listed in the Appendix A and available as supplemental material.
Important here is to notice that the procedure, including single subjects with one condition in two different times, presents a challenge to permutation methods due to the small numbers of volumes available for the permutation. That is why recently, a new permutation approach with an advantage in comparison to SnPM was made available to increase the number of permutations due to sign-flipping function: permutation analysis of linear models (PALM). 21 In the following paragraph, the application of PALM to our data is reported.
PALM -Permutation analysis of linear models: The Permutation Analysis of Linear Models (PALM) was first presented in 2014 and is based on permutation inference applied on general linear models (GLMs). It was originally intended for independent data; however, it has been demonstrated applicable also in certain special cases in which independence is violated. In their work, Winkler et al. have demonstrated that the methods are powerful even in the presence of nuisance effects like reduced number of subjects, unequal group of variances and reduced exchangeability between conditions, providing excellent control of false positives in a wide range of common and relevant imaging research scenarios. 21 To apply the PALM, we used positive IPA-SPECT volumes as input and 12 IPA-SPECT pre-processed negative volumes. Other inputs were a mask image, the design matrix for the GLM, default numbers of permutation with error assumed exchangeable (EE) independent and symmetric (ISE), to allow sign-flipping, and pFWEcorr < 0.05. The scripts are listed in the Appendix A and available as supplemental material.
2.C. Diagnostic assessment
The three statistical inferences were applied independently for each IPA-SPECT volume and each condition (30 min and 3 h). The diagnostic assessment was done in two ways for each statistical approach: first, observing only the table reporting the supra-threshold voxels with cluster bigger than 3 voxels and the cluster of activation, without considering the lesion information from the structural MRI, indicated in the results relatively as SPNnMR/SnPMnMRI/ PALMnMRI; and second projecting the activity on the structural MRI to see if it matched the lesion, indicated in the results relatively as SMPyMRI/SnPMyMRI/PALMyMRI. In the first case the diagnosis was classified as follows: true positive (t+) in case of supra-threshold voxel, true negative (tÀ) in case of no supra-threshold voxel, and, false positive (f+) with supra-threshold voxel forming a cluster less than 3 voxels. In the second case the diagnosis was classified coupled with the MRI information, so when the activated cluster spatially matched the structural lesion visible in the MRI, we registered our results as t+, if the activity was not inside the location of the lesion, the results was registered as f+, in case of no supra-threshold voxel the result was registered as tÀ. Finally, when the activity was located on the border or just outside the lesion, we classified it as false negative (fÀ).
2.D. Visual inspection
The visual inspection of the data was carried on by two independent observers. The full procedure with details is reported in the preview study. 8 The lesions were classified as t+, tÀ, f+, fÀ, unconfirmed positive (u+), and unconfirmed negative (uÀ).
2.E. Analysis of diagnostic performance
The discrimination of the glioma brain tumor performance among different investigation approaches was assessed projecting sensitivity and 100-specificity in a ROC space. 24 To this we used the categorization of the respective diagnostic method in t+, tÀ, f+ and fÀ. As classification variable we used the histological medical report. The analysis included the computation of the area under the trapezoid curve (AUC) defined in the ROC space with one vertex defined by the coordinates of the specific method with the pairwise comparison using the method of DeLong and colleagues. 25 The analysis was performed using MedCalc v.14.10.2 (MedCalc Software, Belgium).
RESULTS
3.A. Diagnosis outcome with the automated methods
Among the 100 patients, seven were excluded from the analysis because the MRI data had big movement artefacts and it was not possible to use it for diagnostic purpose. Based on this dataset, the Visual inspection had a sensitivity of 88% and a specificity of 100%. The SPM obtained a sensitivity of 87% and a specificity of 13%. The SPM&MRI obtained a sensitivity of 87% and specificity of 94%. SnPM obtained sensitivity and the specificity respectively of 81% and 6%. SnPM&MRI had a sensitivity increased to 82% and specificity to 81%. PALM obtained a sensitivity of 81% and specificity of 25%. Finally, PALM&MRI obtained a sensitivity of 88% and specificity of 94%. Figure 4 summarizes the final outcome.
The diagnostic power of the explored statistical methods is clearer if projected in a ROC space where it is illustrated reporting the sensitivity (total true positive/total condition positive in %) vs. the 100-specifity (total true negative/total condition negative). 24 Figure 4 reports the outcome for the diagnostic approaches under study. Compared to VI, the statistical inference methods SPM, SnPM and PALM, lie close to the diagonal (Fig. 2: dotted line in red) suggesting a random classifier for this methodologies, although the non-parametric statistics remain slightly above the diagonal. However, when the inference methods are considered in conjunction with the MRI, the diagnostic power of all of them improve considerably and almost approaches the power of VI (Fig. 4) .
The estimation of the AUC (area under the curve) of the trapezoid with one vertex defined by the coordinates of the diagnostic methods helps us to statistically compare the associate diagnostic power, especially in the situation of very close location in the ROC space. The results showed that classical visual inspection remains the most reliable with an AUC of .935., which is significantly better then SPM [dba (difference between areas)=0.433, z = 8.180, P < 0.0001], the SnPM (dba = 0.369, z = 8.003, P < 0.0001) as well as then PALM (dba = 0.407, z = 6.729, P < 0.0001). However, the diagnostic power of the visual inspection becomes comparable to the most of the automated methodology when the information from the last one is combined with the structural MRI. In this situation we obtained no significant statistical difference in the pairwise comparison of the visual inspection for both SPM&MRI (dba = 0.0312, z = 0.810, P = 0.4181) and PALM&MRI (dba = 0.0248, z = 0.651, P = 0.5150), while for SnPM&MRI the visual approach still remains more significant (dba = 0.120, z = 2.141, P = 0.0323). Remarkable is that PALM&MRI has a very high AUC (=0.910), demonstrating a consequent diagnostic power similar to the classical VI.
The statistical results are resumed in Table III .
DISCUSSION
The results presented above confirm the possibility to outline a glioma diagnosis with automated statistical analysis based on permutation analysis of a linear model (PALM) on IPA-SPECT data. The method, using a threshold of p (FWE) < 0.05 and combined with the structural MRI information, was sensitive to detect 91% of the whole glioma lesion with 88% of sensitivity and 94% of specificity.
The common clinical practice for such diagnosis, and in general for all SPECT images, is the visual inspection performed by an expert clinician of nuclear medicine. It is typically based on a few objective criteria 9, 10 and mostly on personal experience coupled with other quantitative information like other imaging modalities or in case of uncertainty with the well-known invasive histological results. In our data sample, we observed that visual inspection had sensitivity of 88%, similar to PALM&MRI and a higher specificity of 100%. Remarkably the AUC comparison between the two approaches was no longer distinguishable, meaning that an automated analysis has similar power of glioma diagnosis to the classical visual inspection. Interestingly, as Rocha and colleagues pointed out in their work, there is only very scarce bibliography on the verification of degree of concordance between visual assessments and the degree of experience of nuclear medicine clinician involved in this practice. 11 This lead us to believe that there is a benefit of having parallel possibilities to inspect the same data, which could for example improve the confidence in diagnoses made by, but not restricted to, less experienced physicians.
The results we obtained with PALM analysis were rigorously achieved and they could have been improved with a more powerful acquisition paradigm, for instance by simply collecting a greater numbers of volumes for single subject. In addition, once the control group is collected there is no need to re-collect it a second time.
As already pointed out, the results obtained with SPM and SnPM were only explorative, and due to the small data samples, not rigorous, despite the good results that SPM seems to have obtained even in this abnormal condition. In order to improve the results it would be sufficient to design an acquisition protocol ad hoc, for example, by simply increasing the number of volumes acquired for each patient during the nuclear imaging session. We believe that the evaluation of this issue is of big importance due to possible application in automated guided brain surgery. Indeed, our results showed a very vivid impression of the spatial, three -dimensional extension of the tumor mass, with precise stereotactic coordinate and reliable projection in the high structural MRI (Fig. 5) .
Here, it is important to notice that the extension of the tumor delineated with SPECT is related to the active functional tumor tissue, while with the MRI and the CT it is only possible to retrieve information about abnormal structures. This lead to several remarkable applications, for example, in neurosurgery for the resection of brain cancer tissues and, since the foci is in stereotactic coordinate, it can have application in stereotactic radiosurgery or generally in beam radiation therapy. Moreover, the entire work flow, here described for IPA-SPECT data, can be generally applied to other disease-specific molecular radio tracer.
CONCLUSION
In conclusion, our results proved the method of statistical non-& parametric mapping to be capable of detecting glioma positive in IPA -SPECT data. These statistical frameworks can be universally applied to SPECT data after having TABLE III. AUC and pairwise comparison between the classical visual inspection and the investigated automated methods. If the automated methods are combined with the information from the structural MRI, the discrimination performance is getting closer to the visual inspection one. Noticeably, PALMyMRI has an AUC smaller only of 3% in comparison to the visual inspection (bold underline values in Table III submitted the patient`s data to a consistent spatial pre-processing. No further individual modification or processing is required to get diagnostically conclusive results. Compared to the parametric approach, the non-parametric approach is the mathematically more appropriate method and provides results equivalent to the visual investigation. We believe that it is possible to improve the outcome with a dedicate acquisition paradigm. Overall, the automated statistical approach as a diagnostic instrument for glioma tumors in IPA-SPECT data seems to be a promising tool to support the visual investigation in nuclear medicine.
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